248 related articles for article (PubMed ID: 26405178)
1. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.
Xiong R; Zhou W; Siegel D; Kitson RR; Freed CR; Moody CJ; Ross D
Mol Pharmacol; 2015 Dec; 88(6):1045-54. PubMed ID: 26405178
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
4. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.
Jiang TF; Zhang YJ; Zhou HY; Wang HM; Tian LP; Liu J; Ding JQ; Chen SD
J Neuroimmune Pharmacol; 2013 Mar; 8(1):356-69. PubMed ID: 23325107
[TBL] [Abstract][Full Text] [Related]
5. 19-substituted benzoquinone ansamycin heat shock protein-90 inhibitors: biological activity and decreased off-target toxicity.
Chang CH; Drechsel DA; Kitson RR; Siegel D; You Q; Backos DS; Ju C; Moody CJ; Ross D
Mol Pharmacol; 2014 Jun; 85(6):849-57. PubMed ID: 24682466
[TBL] [Abstract][Full Text] [Related]
6. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
8. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
Riedel M; Goldbaum O; Schwarz L; Schmitt S; Richter-Landsberg C
PLoS One; 2010 Jan; 5(1):e8753. PubMed ID: 20090920
[TBL] [Abstract][Full Text] [Related]
9. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
[TBL] [Abstract][Full Text] [Related]
10. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
11. Radicicol rescues yeast cell death triggered by expression of human α-synuclein and its A53T mutant, but not by human βA4 peptide and proapoptotic protein bax.
Derf A; Verekar SA; Jain SK; Deshmukh SK; Bharate SB; Chaudhuri B
Bioorg Chem; 2019 Apr; 85():152-158. PubMed ID: 30612081
[TBL] [Abstract][Full Text] [Related]
12. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells.
Yu W; Chen S; Cao L; Tang J; Xiao W; Xiao B
Cell Biol Toxicol; 2018 Aug; 34(4):291-303. PubMed ID: 29214369
[TBL] [Abstract][Full Text] [Related]
14. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
15. P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
McCollum AK; TenEyck CJ; Stensgard B; Morlan BW; Ballman KV; Jenkins RB; Toft DO; Erlichman C
Cancer Res; 2008 Sep; 68(18):7419-27. PubMed ID: 18794130
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells.
Mori M; Hitora T; Nakamura O; Yamagami Y; Horie R; Nishimura H; Yamamoto T
Int J Oncol; 2015 Jan; 46(1):47-54. PubMed ID: 25351442
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers.
Daturpalli S; Waudby CA; Meehan S; Jackson SE
J Mol Biol; 2013 Nov; 425(22):4614-28. PubMed ID: 23948507
[TBL] [Abstract][Full Text] [Related]
18. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity.
Putcha P; Danzer KM; Kranich LR; Scott A; Silinski M; Mabbett S; Hicks CD; Veal JM; Steed PM; Hyman BT; McLean PJ
J Pharmacol Exp Ther; 2010 Mar; 332(3):849-57. PubMed ID: 19934398
[TBL] [Abstract][Full Text] [Related]
19. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
[TBL] [Abstract][Full Text] [Related]
20. Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.
Anandhan A; Lei S; Levytskyy R; Pappa A; Panayiotidis MI; Cerny RL; Khalimonchuk O; Powers R; Franco R
Mol Neurobiol; 2017 Jul; 54(5):3825-3842. PubMed ID: 27324791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
